Related Experiment Video
Updated: Jun 23, 2026

08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Isosorbide dinitrate and pulsatile arterial haemodynamic variables in hypertension
European Heart Journal
|October 1, 1986
Summary
Sustained-release isosorbide dinitrate (ISDN) effectively lowers blood pressure in hypertensive patients. This preparation also improves large artery function and enhances blood flow in the forearm.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Hypertension Research
Background:
- Essential hypertension is a prevalent condition affecting cardiovascular health.
- Understanding the vascular effects of antihypertensive medications is crucial for treatment optimization.
Purpose of the Study:
- To evaluate the impact of sustained-release oral isosorbide dinitrate (ISDN) on cerebral and forearm circulation in patients with essential hypertension.
- To assess the non-invasive hemodynamic and arterial properties following ISDN administration.
Main Methods:
- Pulsed Doppler velocimetry was used to measure blood flow and velocity in carotid and brachial arteries.
- Strain gauge arterial mechanography recorded forearm pulse wave velocity for compliance and impedance analysis.
- Hemodynamic parameters including blood pressure, heart rate, and vascular resistance were monitored.
Main Results:
- ISDN significantly reduced blood pressure without altering heart rate.
- Arterial diameter increased in both carotid and brachial arteries; forearm blood flow also increased.
- Vascular resistance decreased in both beds, with improved large artery compliance and reduced pulse wave velocity and impedance.
Conclusions:
- Sustained-release ISDN demonstrates potent antihypertensive effects.
- The medication induces significant vasodilation in both small and large arteries.
- ISDN improves pulsatile hemodynamics and arterial compliance in hypertensive individuals.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Measurement of Blood Pressure
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

